Literature DB >> 23303669

Chaperone-like activity of high-mobility group box 1 protein and its role in reducing the formation of polyglutamine aggregates.

Hyun Jin Min1, Eun Ae Ko, Jie Wu, Eun Sung Kim, Min Kyung Kwon, Man Sup Kwak, Ji Eun Choi, Jong Eun Lee, Jeon-Soo Shin.   

Abstract

High-mobility group box 1 protein (HMGB1), which mainly exists in the nucleus, has recently been shown to function as a sentinel molecule for viral nucleic acid sensing and an autophagy regulator in the cytoplasm. In this study, we studied the chaperone-like activity of HMGB1 and found that HMGB1 inhibited the chemically induced aggregation of insulin and lysozyme, as well as the heat-induced aggregation of citrate synthase. HMGB1 also restored the heat-induced suppression of cytoplasmic luciferase activity as a reporter protein in hamster lung fibroblast O23 cells with expression of HMGB1. Next, we demonstrated that HMGB1 inhibited the formation of aggregates and toxicity caused by expanded polyglutamine (polyQ), one of the main causes of Huntington disease. HMGB1 directly interacted with polyQ on immunofluorescence and coimmunoprecipitation assay, whereas the overexpression of HMGB1 or exogenous administration of recombinant HMGB1 protein remarkably reduced polyQ aggregates in SHSY5Y cells and hmgb1(-/-) mouse embryonic fibroblasts upon filter trap and immunofluorescence assay. Finally, overexpressed HMGB1 proteins in mouse embryonic primary striatal neurons also bound to polyQ and decreased the formation of polyQ aggregates. To this end, we have demonstrated that HMGB1 exhibits chaperone-like activity and a possible therapeutic candidate in polyQ disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23303669      PMCID: PMC3566580          DOI: 10.4049/jimmunol.1202472

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Authors:  Tiziana Bonaldi; Fabio Talamo; Paola Scaffidi; Denise Ferrera; Annalisa Porto; Angela Bachi; Anna Rubartelli; Alessandra Agresti; Marco E Bianchi
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

2.  Mutation of alpha B-crystallin: effects on chaperone-like activity.

Authors:  J Horwitz; M Bova; Q L Huang; L Ding; O Yaron; S Lowman
Journal:  Int J Biol Macromol       Date:  1998 May-Jun       Impact factor: 6.953

Review 3.  Molecular chaperones in protein folding and proteostasis.

Authors:  F Ulrich Hartl; Andreas Bracher; Manajit Hayer-Hartl
Journal:  Nature       Date:  2011-07-20       Impact factor: 49.962

4.  Treatment with extracellular HSP70/HSC70 protein can reduce polyglutamine toxicity and aggregation.

Authors:  Tatiana V Novoselova; Boris A Margulis; Sergey S Novoselov; Alexander M Sapozhnikov; Jacqueline van der Spuy; Michael E Cheetham; Irina V Guzhova
Journal:  J Neurochem       Date:  2005-06-30       Impact factor: 5.372

5.  Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock.

Authors:  M Ombrellino; H Wang; M S Ajemian; A Talhouk; L A Scher; S G Friedman; K J Tracey
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

6.  The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities.

Authors:  Jurre Hageman; Maria A W H van Waarde; Alicja Zylicz; Dawid Walerych; Harm H Kampinga
Journal:  Biochem J       Date:  2011-04-01       Impact factor: 3.857

Review 7.  HMGB1 and RAGE in inflammation and cancer.

Authors:  Gary P Sims; Daniel C Rowe; Svend T Rietdijk; Ronald Herbst; Anthony J Coyle
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

8.  Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity.

Authors:  N R Jana; M Tanaka; G h Wang; N Nukina
Journal:  Hum Mol Genet       Date:  2000-08-12       Impact factor: 6.150

9.  Hsp70 and its molecular role in nervous system diseases.

Authors:  Giuseppina Turturici; Gabriella Sconzo; Fabiana Geraci
Journal:  Biochem Res Int       Date:  2011-02-24

10.  Progressive disruption of cellular protein folding in models of polyglutamine diseases.

Authors:  Tali Gidalevitz; Anat Ben-Zvi; Kim H Ho; Heather R Brignull; Richard I Morimoto
Journal:  Science       Date:  2006-02-09       Impact factor: 63.714

View more
  18 in total

1.  HMGB1 is involved in autophagy inhibition caused by SNCA/α-synuclein overexpression: a process modulated by the natural autophagy inducer corynoxine B.

Authors:  Ju-Xian Song; Jia-Hong Lu; Liang-Feng Liu; Lei-Lei Chen; Siva Sundara Kumar Durairajan; Zhenyu Yue; Hong-Qi Zhang; Min Li
Journal:  Autophagy       Date:  2013-01-01       Impact factor: 16.016

Review 2.  Exploring the role of high-mobility group box 1 (HMGB1) protein in the pathogenesis of Huntington's disease.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  J Mol Med (Berl)       Date:  2020-02-08       Impact factor: 4.599

Review 3.  Inflammation in neurodegenerative diseases--an update.

Authors:  Sandra Amor; Laura A N Peferoen; Daphne Y S Vogel; Marjolein Breur; Paul van der Valk; David Baker; Johannes M van Noort
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

4.  High mobility group box 1 (HMGB1) phenotypic role revealed with stress.

Authors:  Daolin Tang; Rui Kang; Bennett Van Houten; Herbert J Zeh; Timothy R Billiar; Michael T Lotze
Journal:  Mol Med       Date:  2014-08-19       Impact factor: 6.354

Review 5.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

6.  HMGB1-dependent and -independent autophagy.

Authors:  Xiaofang Sun; Daolin Tang
Journal:  Autophagy       Date:  2014-08-13       Impact factor: 16.016

Review 7.  The role of high mobility group box 1 in innate immunity.

Authors:  Shin-Ae Lee; Man Sup Kwak; Sol Kim; Jeon-Soo Shin
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759

8.  Role of high mobility group box 1 (HMGB1) in SCA17 pathogenesis.

Authors:  Li-Ching Lee; Chiung-Mei Chen; Pin-Rong Wang; Ming-Tsan Su; Guey-Jen Lee-Chen; Chun-Yen Chang
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

Review 9.  Sterile Neuroinflammation and Strategies for Therapeutic Intervention.

Authors:  Manoj Banjara; Chaitali Ghosh
Journal:  Int J Inflam       Date:  2017-01-03

10.  The unfolded protein response and its potential role in Huntington's disease elucidated by a systems biology approach.

Authors:  Ravi Kiran Reddy Kalathur; Joaquin Giner-Lamia; Susana Machado; Tania Barata; Kameshwar R S Ayasolla; Matthias E Futschik
Journal:  F1000Res       Date:  2015-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.